Physician profile
Drorit Or
NPI 1851533509
$905.36
in general payments reported to CMS, 2019-2025
14 companies · $79.92 in 2025
The $79.92 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $11.26 · 2021: $173 · 2022: $45.70 · 2023: $35.19 · 2024: $200 · 2025: $79.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $360.08 | 2019 | |
| Astellas Pharma Global Development | $98.81 | 2024 | Veozah |
| Intuitive Surgical, INC. | $84.11 | 2024-2025 | |
| Hologic Sales and Service, LLC | $73.13 | 2025 | Acessa Provu System |
| Medtronic, INC. | $51.13 | 2021 | |
| Pfizer INC. | $39.31 | 2021 | |
| Abbvie INC. | $39.30 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $35.19 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $26.83 | 2021 | |
| Boston Scientific Corporation | $24.34 | 2024 | Watchman Flx |
| Axonics, INC. | $23.01 | 2022 | |
| Coopersurgical, INC. | $22.69 | 2022 | |
| Amgen INC. | $15.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drorit Or listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.